| Application no. and date | 23202349.9 (espacenet) (Federated) (European Patent Register), 20200325 | | Patent/reg. no. and date | DK/EP 4316521, 20250618 | | Publication date | 20240207 | | Priority no. and date | CN 201910231203, 20190326 | | EP pub. no. and date |
EP 4316521 20240207 | | Effective date | | | Applicant/owner | RemeGen Co., Ltd., China (Shandong) Pilot Free Trade Zone
Yantai District, Yantai Development Zone
No.58 Beijing Middle Road
Shandong 264006, CN | | Applicant ref. no. | | | Inventor | LI, Zhuanglin,
Shandong, 264006, CN,
XU, Qiaoyu,
Shandong, 264006, CN,
YAO, Xuejing,
Shandong, 264006, CN,
BAO, Qianjing,
Shandong, 264006, CN,
FANG, Jianmin,
Shandong, 264006, CN | | Representative | | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/20 (2006.01) , A61K 47/65 (2017.01) , A61K 47/68 (2017.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) , A61P 35/00 (2006.01) | | Title | ANTI-HER2 ANTIBODY DRUG CONJUGATE PHARMACEUTICAL PREPARATION | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
